Statin Use and the Risks of Delirium and Short-Term Mortality in Hospitalized Adults: An Updated Systematic Review and Meta-Analysis
Open Access
- 9 October 2026
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2291
Abstract
Background/Objectives: Delirium is a common and serious neuropsychiatric complication in hospitalized and critically ill patients and is associated with prolonged hospitalization and increased mortality. Previous meta-analyses found no clear association between statin use and delirium; however, newly published studies and emerging mortality data warrant re-evaluation. Methods: This updated systematic review and meta-analysis extended a previous meta-analysis and re-evaluated the association between statin use and delirium risk. PubMed, Embase, and the Cochrane Library were searched for eligible studies published from January 2022 through October 2025. Study-level estimates were synthesized using random-effects models. Because ORs, RRs, and HRs are not directly interchangeable, the combined synthesis was considered exploratory. Sensitivity analyses included an OR-only dataset, exclusion of the cross-sectional study, REML models with Hartung–Knapp adjustment, and restriction to observational studies reporting multivariable-adjusted ORs. Results: Nineteen studies (5 randomized controlled trials and 14 observational studies) involving 440,737 participants were included. The exploratory combined analysis yielded an OR of 0.79 (95% confidence interval [CI] 0.66–0.95; p = 0.01; I2 = 90%). Results differed by study design: randomized trials yielded a lower pooled point estimate (OR 0.41, 95% CI 0.20–0.82; I2 = 58%), whereas the pooled association among observational studies was not statistically significant (OR 0.86, 95% CI 0.71–1.03; I2 = 91%; p for subgroup difference = 0.04). However, in the three randomized trials contributing to incident delirium, REML with Hartung–Knapp adjustment substantially widened the confidence interval (OR 0.41, 95% CI 0.09–1.86; p = 0.126). In the overall analysis, REML–Hartung–Knapp inference also increased uncertainty (OR 0.79, 95% CI 0.62–1.00; p = 0.047), as did restriction to multivariable-adjusted observational ORs (OR 0.76, 95% CI 0.57–1.01; p = 0.062). In four studies comprising 21,687 participants, statin use was associated with lower 30-day all-cause mortality under the conventional random-effects model (OR 0.52, 95% CI 0.35–0.79; p = 0.002; I2 = 88%); this estimate remained similar under REML with Hartung–Knapp adjustment (OR 0.52, 95% CI 0.32–0.84; p = 0.022). No significant association was observed for delirium-free days. Conclusions: The available evidence suggests a possible association between statin exposure and lower delirium occurrence, but substantial heterogeneity, differences between randomized and observational evidence, and sensitivity to analytic assumptions limit causal interpretation. The findings do not establish statins as a preventive treatment for delirium or prove a mortality benefit. Further adequately powered randomized trials with clearly defined exposure timing and standardized delirium assessment are warranted.Keywords
This publication has 32 references indexed in Scilit:
- Association Between Statin Use in the Intensive Care Unit and Delirium in Patients Receiving Mechanical Ventilation: A Cross‐Sectional StudyHealth Science Reports, 2025
- Statins Reduce Delirium Risk in Older Adults With Type 2 DiabetesJournal of the American Medical Directors Association, 2025
- The economic cost of delirium: A systematic review and quality assessmentAlzheimer's & Dementia, 2021
- Pleiotropic effects of statins on brain cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2020
- The Role of Perioperative Statin Use in the Prevention of Delirium After Total Knee Replacement Under Spinal AnesthesiaThe Journal of Arthroplasty, 2018
- Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation (MoDUS): a randomised, double-blind, placebo-controlled trialThe Lancet Respiratory Medicine, 2017
- Role of statins in delirium prevention in critical ill and cardiac surgery patients: A systematic review and meta-analysisJournal of Critical Care, 2017
- Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trialThe Lancet Respiratory Medicine, 2016
- Preoperative Statin Therapy Is Not Associated With a Decrease in the Incidence of Delirium After Cardiac OperationsThe Annals of Thoracic Surgery, 2012
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010